571 related articles for article (PubMed ID: 6100649)
1. HTLV and immunosuppression.
Essex M; Kanki P; Allan J; Barin F; McLane MF; Lee TH; Kitchen L; Homma T; Malone G; Yokota T
Princess Takamatsu Symp; 1984; 15():309-18. PubMed ID: 6100649
[TBL] [Abstract][Full Text] [Related]
2. Retroviruses associated with leukemia and ablative syndromes in animals and in human beings.
Essex M; McLane MF; Kanki P; Allan J; Kitchen L; Lee TH
Cancer Res; 1985 Sep; 45(9 Suppl):4534s-4538s. PubMed ID: 2990682
[TBL] [Abstract][Full Text] [Related]
3. Human T-cell leukemia virus specific antigens.
Lee TH; Coligan JE; Essex M
Princess Takamatsu Symp; 1984; 15():197-203. PubMed ID: 6100639
[TBL] [Abstract][Full Text] [Related]
4. HTLV-III infection in homosexuals and hemophiliacs in Sweden.
Biberfeld G; Böttiger B; Karlsson A; Sandström E; Morfeldt-Månsson L; Blombäck M; Nilsson IM; Wiechel B; Saxinger C; Gallo R
Cancer Res; 1985 Sep; 45(9 Suppl):4609s-4611s. PubMed ID: 2990693
[TBL] [Abstract][Full Text] [Related]
5. Detection of antibodies to HTLV-I and -III in sera from Japanese hemophiliacs.
Abe T; Kinoshita T; Matsuda J; Ryu T; Ting RC; Aoki T; Robert-Guroff M; Miyakoshi H; Gallo RC
Cancer Res; 1985 Sep; 45(9 Suppl):4621s-4623s. PubMed ID: 2990696
[TBL] [Abstract][Full Text] [Related]
6. Human retroviral env and gag polypeptides: serologic assays to measure infection.
Kanner SB; Cheng-Mayer C; Geffin RB; Parks WP; Beltz GA; Arthur LO; Samuel KP; Papas TS
J Immunol; 1986 Jul; 137(2):674-8. PubMed ID: 3014000
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of antibodies to human T-cell leukemia/lymphoma virus type I and human immunodeficiency virus in Japanese immigrant colonies in Bolivia and Bolivian natives.
Ohtsu T; Tsugane S; Tobinai K; Shimoyama M; Nanri S; Watanabe S
Jpn J Cancer Res; 1987 Dec; 78(12):1347-53. PubMed ID: 2892821
[TBL] [Abstract][Full Text] [Related]
8. Current status and strategies for vaccines against diseases induced by human T-cell lymphotropic retroviruses (HTLV-I, -II, -III).
Fischinger PJ; Robey WG; Koprowski H; Gallo RC; Bolognesi DP
Cancer Res; 1985 Sep; 45(9 Suppl):4694s-4699s. PubMed ID: 2410115
[TBL] [Abstract][Full Text] [Related]
9. Sera from HTLV-III/LAV antibody-positive individuals mediate antibody-dependent cellular cytotoxicity against HTLV-III/LAV-infected T cells.
Rook AH; Lane HC; Folks T; McCoy S; Alter H; Fauci AS
J Immunol; 1987 Feb; 138(4):1064-7. PubMed ID: 3027168
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of antibodies to AIDS-associated retrovirus in in- and out-patients in Japan.
Ikegami N
AIDS Res; 1986 Dec; 2 Suppl 1():S29-34. PubMed ID: 3103640
[TBL] [Abstract][Full Text] [Related]
11. Immunological properties of HTLV-III antigens recognized by sera of patients with AIDS and AIDS-related complex and of asymptomatic carriers of HTLV-III infection.
Sarngadharan MG; diMarzo Veronese F; Lee S; Gallo RC
Cancer Res; 1985 Sep; 45(9 Suppl):4574s-4577s. PubMed ID: 2410106
[TBL] [Abstract][Full Text] [Related]
12. Structural and epidemiological features of primate lymphotropic retroviruses.
Hunsmann G; Schneider J; Bayer H; Jurkiewicz E; Yamamoto N
Princess Takamatsu Symp; 1984; 15():109-18. PubMed ID: 6100632
[TBL] [Abstract][Full Text] [Related]
13. Time relationship of immune changes to HTLV-III/LAV seroconversion in patients with hemophilia.
Knutsen AP; Bouhasin JD; Lawrence DN; Roodman ST; Mueller KR; McDougal JS; Joist JH
Ann Allergy; 1986 Nov; 57(5):376-84. PubMed ID: 2946253
[TBL] [Abstract][Full Text] [Related]
14. Unique pattern of HTLV-III (AIDS-related) antigen recognition by sera from African children in Uganda (1972).
Saxinger C; Levine PH; Dean A; Lange-Wantzin G; Gallo R
Cancer Res; 1985 Sep; 45(9 Suppl):4624s-4626s. PubMed ID: 2990697
[TBL] [Abstract][Full Text] [Related]
15. Clinical and immunological findings in HTLV-III infection.
Krohn KJ; Antonen J; Valle SL; Kazakevicius R; Saxinger C; Gallo RC; Ranki A
Cancer Res; 1985 Sep; 45(9 Suppl):4612s-4615s. PubMed ID: 2990694
[TBL] [Abstract][Full Text] [Related]
16. Human T-cell leukemia-lymphoma virus type 1 and adult T-cell leukemia-lymphoma in Okinawa.
Clark JW; Robert-Guroff M; Ikehara O; Henzan E; Blattner WA
Cancer Res; 1985 Jun; 45(6):2849-52. PubMed ID: 2985255
[TBL] [Abstract][Full Text] [Related]
17. Monoclonal antibodies reactive with human T cell lymphotropic virusI (HTLVI) p19 internal core protein: cross-reactivity with normal tissues and differential reactivity with HTLV types I and II.
Palker TJ; Scearce RM; Ho W; Copeland TD; Oroszlan S; Popovic M; Haynes BF
J Immunol; 1985 Jul; 135(1):247-54. PubMed ID: 2987346
[TBL] [Abstract][Full Text] [Related]
18. Human T-cell leukemia virus: its discovery and role in leukemogenesis and immunosuppression.
Shaw GM; Broder S; Essex M; Gallo RC
Adv Intern Med; 1984; 30():1-27. PubMed ID: 6084947
[TBL] [Abstract][Full Text] [Related]
19. Structural and antigenic characterization of the proteins of human T-cell leukemia viruses and their relationships to the gene products of other retroviruses.
Oroszlan S; Copeland TD; Rice NR; Smythers GW; Tsai WP; Yoshinaka Y; Shimotohno K
Princess Takamatsu Symp; 1984; 15():147-57. PubMed ID: 6100635
[TBL] [Abstract][Full Text] [Related]
20. Impairment of cellular immunity and OKT4 lymphocytes in symptom-free hemophiliacs with antibodies to human T leukemia virus III (HTLV III).
Pandolfi F; De Rossi G; Mariani G; Carbonari M; Ensoli B; Napolitano M; Lopez M; Mandelli F; Aiuti F
Diagn Immunol; 1985; 3(3):155-9. PubMed ID: 2996821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]